(PUK) Prudential - Overview
Sector: Financial ServicesIndustry: Insurance - Life | Exchange NYSE (USA) | Currency USD | Market Cap: 35.870m | Total Return 31% in 12m
Stock: Life Insurance, Health Insurance, Asset Management, Savings, Investments
Total Rating 68
Risk 35
Buy Signal -0.59
| Risk 5d forecast | |
|---|---|
| Volatility | 33.1% |
| Relative Tail Risk | 2.86% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.97 |
| Alpha | 21.47 |
| Character TTM | |
|---|---|
| Beta | 0.970 |
| Beta Downside | 1.969 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.19% |
| CAGR/Max DD | 0.05 |
Description: PUK Prudential March 06, 2026
Prudential plc (PUK) is an insurance and asset management company operating in Asia and Africa.
The company offers life and health insurance, savings, investments, wealth management, and foreign exchange services. The insurance sector is characterized by long-term liabilities and capital-intensive operations.
Founded in 1848, PUK is headquartered in Hong Kong. Its business model focuses on providing financial protection and wealth accumulation products.
For more detailed financial analysis, consider exploring ValueRay.
Headlines to watch out for
- Asian middle-class growth fuels insurance product demand
- Regulatory changes impact Chinese market access
- Investment performance directly affects asset management fees
- Exchange rate fluctuations influence reported earnings
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 5.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 3.04 > 1.0 |
| NWC/Revenue: 28.53% < 20% (prev -1.47k%; Δ 1.50k% < -1%) |
| CFO/TA 0.03 > 3% & CFO 5.31b > Net Income 5.53b |
| Net Debt (-1.24b) to EBITDA (15.89b): -0.08 < 3 |
| Current Ratio: error (cannot be calculated; needs correct Total Current Assets and Liabilities) |
| Outstanding Shares: last quarter (1.29b) vs 12m ago -6.33% < -2% |
| Gross Margin: 62.29% > 18% (prev 0.37%; Δ 6.19k% > 0.5%) |
| Asset Turnover: 20.29% > 50% (prev 4.98%; Δ 15.30% > 0%) |
| Interest Coverage Ratio: 44.51 > 6 (EBITDA TTM 15.89b / Interest Expense TTM 312.0m) |
Altman Z'' 1.26
| A: 0.06 (Total Current Assets 9.59b - Total Current Liabilities 0.0) / Total Assets 157.48b |
| B: 0.07 (Retained Earnings 10.45b / Total Assets 157.48b) |
| C: 0.08 (EBIT TTM 13.89b / Avg Total Assets 165.77b) |
| D: 0.08 (Book Value of Equity 11.21b / Total Liabilities 141.63b) |
| Altman-Z'' Score: 1.26 = BB |
Beneish M -1.76
| DSRI: 0.45 (Receivables 3.88b/2.21b, Revenue 33.63b/8.67b) |
| GMI: 0.60 (GM 62.29% / 37.25%) |
| AQI: 1.02 (AQ_t 0.94 / AQ_t-1 0.92) |
| SGI: 3.88 (Revenue 33.63b / 8.67b) |
| TATA: 0.00 (NI 5.53b - CFO 5.31b) / TA 157.48b) |
| Beneish M-Score: -1.76 (Cap -4..+1) = CCC |
What is the price of PUK shares?
As of March 28, 2026, the stock is trading at USD 27.78 with a total of 1,173,237 shares traded.
Over the past week, the price has changed by -1.37%, over one month by -8.53%, over three months by -10.11% and over the past year by +31.02%.
Over the past week, the price has changed by -1.37%, over one month by -8.53%, over three months by -10.11% and over the past year by +31.02%.
Is PUK a buy, sell or hold?
Prudential has received a consensus analysts rating of 4.67.
Therefore, it is recommended to buy PUK.
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PUK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 37.4 | 34.7% |
| Analysts Target Price | 37.4 | 34.7% |
PUK Fundamental Data Overview March 24, 2026
P/E Trailing = 9.2899
P/E Forward = 13.3511
P/S = 2.4863
P/B = 1.7811
P/EG = 1.3085
Revenue TTM = 33.63b USD
EBIT TTM = 13.89b USD
EBITDA TTM = 15.89b USD
Long Term Debt = 4.48b USD (from longTermDebt, two quarters ago)
Short Term Debt = 500.0m USD (from shortTermDebt, two quarters ago)
Debt = 4.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.24b USD (from netDebt column, last quarter)
Enterprise Value = 34.63b USD (35.87b + Debt 4.48b - CCE 5.72b)
Interest Coverage Ratio = 44.51 (Ebit TTM 13.89b / Interest Expense TTM 312.0m)
EV/FCF = 7.36x (Enterprise Value 34.63b / FCF TTM 4.71b)
FCF Yield = 13.60% (FCF TTM 4.71b / Enterprise Value 34.63b)
FCF Margin = 14.00% (FCF TTM 4.71b / Revenue TTM 33.63b)
Net Margin = 16.43% (Net Income TTM 5.53b / Revenue TTM 33.63b)
Gross Margin = 62.29% ((Revenue TTM 33.63b - Cost of Revenue TTM 12.68b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.22 (Enterprise Value 34.63b / Total Assets 157.48b)
Interest Expense / Debt = 1.58% (Interest Expense 71.0m / Debt 4.48b)
Taxrate = 14.66% (350.5m / 2.39b)
NOPAT = 11.85b (EBIT 13.89b * (1 - 14.66%))
Current Ratio = unknown (Total Current Assets 9.59b / Total Current Liabilities 0.0)
Debt / Equity = 0.30 (Debt 4.48b / totalStockholderEquity, last quarter 14.93b)
Debt / EBITDA = -0.08 (Net Debt -1.24b / EBITDA 15.89b)
Debt / FCF = -0.26 (Net Debt -1.24b / FCF TTM 4.71b)
Total Stockholder Equity = 16.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.33% (Net Income 5.53b / Total Assets 157.48b)
RoE = 33.13% (Net Income TTM 5.53b / Total Stockholder Equity 16.68b)
RoCE = 65.63% (EBIT 13.89b / Capital Employed (Equity 16.68b + L.T.Debt 4.48b))
RoIC = 54.00% (NOPAT 11.85b / Invested Capital 21.95b)
WACC = 8.51% (E(35.87b)/V(40.35b) * Re(9.40%) + D(4.48b)/V(40.35b) * Rd(1.58%) * (1-Tc(0.15)))
Discount Rate = 9.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.22%
[DCF] Terminal Value 68.39% ; FCFF base≈4.71b ; Y1≈3.09b ; Y5≈1.41b
[DCF] Fair Price = 21.45 (EV 25.70b - Net Debt -1.24b = Equity 26.94b / Shares 1.26b; r=8.51% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -4.59 | EPS CAGR: -1.57% | SUE: 4.0 | # QB: 1
Revenue Correlation: 18.89 | Revenue CAGR: 13.98% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=2.36 | Chg7d=+0.046 | Chg30d=+0.046 | Revisions Net=-1 | Growth EPS=+16.9% | Growth Revenue=+22.3%
P/E Forward = 13.3511
P/S = 2.4863
P/B = 1.7811
P/EG = 1.3085
Revenue TTM = 33.63b USD
EBIT TTM = 13.89b USD
EBITDA TTM = 15.89b USD
Long Term Debt = 4.48b USD (from longTermDebt, two quarters ago)
Short Term Debt = 500.0m USD (from shortTermDebt, two quarters ago)
Debt = 4.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.24b USD (from netDebt column, last quarter)
Enterprise Value = 34.63b USD (35.87b + Debt 4.48b - CCE 5.72b)
Interest Coverage Ratio = 44.51 (Ebit TTM 13.89b / Interest Expense TTM 312.0m)
EV/FCF = 7.36x (Enterprise Value 34.63b / FCF TTM 4.71b)
FCF Yield = 13.60% (FCF TTM 4.71b / Enterprise Value 34.63b)
FCF Margin = 14.00% (FCF TTM 4.71b / Revenue TTM 33.63b)
Net Margin = 16.43% (Net Income TTM 5.53b / Revenue TTM 33.63b)
Gross Margin = 62.29% ((Revenue TTM 33.63b - Cost of Revenue TTM 12.68b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.22 (Enterprise Value 34.63b / Total Assets 157.48b)
Interest Expense / Debt = 1.58% (Interest Expense 71.0m / Debt 4.48b)
Taxrate = 14.66% (350.5m / 2.39b)
NOPAT = 11.85b (EBIT 13.89b * (1 - 14.66%))
Current Ratio = unknown (Total Current Assets 9.59b / Total Current Liabilities 0.0)
Debt / Equity = 0.30 (Debt 4.48b / totalStockholderEquity, last quarter 14.93b)
Debt / EBITDA = -0.08 (Net Debt -1.24b / EBITDA 15.89b)
Debt / FCF = -0.26 (Net Debt -1.24b / FCF TTM 4.71b)
Total Stockholder Equity = 16.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.33% (Net Income 5.53b / Total Assets 157.48b)
RoE = 33.13% (Net Income TTM 5.53b / Total Stockholder Equity 16.68b)
RoCE = 65.63% (EBIT 13.89b / Capital Employed (Equity 16.68b + L.T.Debt 4.48b))
RoIC = 54.00% (NOPAT 11.85b / Invested Capital 21.95b)
WACC = 8.51% (E(35.87b)/V(40.35b) * Re(9.40%) + D(4.48b)/V(40.35b) * Rd(1.58%) * (1-Tc(0.15)))
Discount Rate = 9.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.22%
[DCF] Terminal Value 68.39% ; FCFF base≈4.71b ; Y1≈3.09b ; Y5≈1.41b
[DCF] Fair Price = 21.45 (EV 25.70b - Net Debt -1.24b = Equity 26.94b / Shares 1.26b; r=8.51% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -4.59 | EPS CAGR: -1.57% | SUE: 4.0 | # QB: 1
Revenue Correlation: 18.89 | Revenue CAGR: 13.98% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=2.36 | Chg7d=+0.046 | Chg30d=+0.046 | Revisions Net=-1 | Growth EPS=+16.9% | Growth Revenue=+22.3%